Find your next paid study

New York UniversityNCT06981598

Actual pay is set by the research site.

Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy

The project will include 30 patients with bladder cancer who are candidates for bladder removal. After signing the consent form, the study team will collect so…

Bladder Cancer

Duke UniversityNCT06986304

Actual pay is set by the research site.

HypertensionCardiovascular DiseasesCardiovascular Risk Factors+2 more

Sleep and Circadian Mechanisms in Hypertension

This study is a mechanistic clinical trial designed to investigate the effects of the circadian system and sleep on non-dipping blood pressure (BP) in people w…

Oregon Health and Science UniversityNCT05184933

Actual pay is set by the research site.

CAD - Coronary Artery Disease

Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care

REFINE-CAC is a prospective, multi-center trial assessing the management of asymptomatic participants with CAC scores 1-299 Agatston units or incidental CAC fi…

HeartFlow, Inc.NCT07853716

~$10 – $1,050

Actual pay is set by the research site.

Pancreatic CancerBorderline Resectable Pancreatic CancerLocally Advanced Pancreatic Cancer

A Randomized, Multicenter, Multiregional, Pivotal Clinical Trial to Evaluate the Safety and Efficacy of IMD10 (Focused Ultrasound) in Combination With the Chemotherapy Regimen Consisting of Irinotecan Hydrochloride, Oxaliplatin, Fluorouracil (5-FU) and Leucovorin Improves Overall Survival Compared With the Chemotherapy Regimen Alone in Patients With Borderline Resectable Pancreatic Cancer or Locally Advanced Pancreatic Cancer

The purpose of this Interventional clinical trial is to evaluate safety and efficacy of 'IMD10 (focused ultrasound)' in the treatment of borderline resectable …

IMGT Co., Ltd.NCT07325214

~$10 – $1,050

Actual pay is set by the research site.

Phase 1

Phase 1 Trial of Safety and Preliminary Efficacy of Segmental Ablative Radioembolization in Combination With Tremelimumab Plus Durvalumab (MEDI4736) in Patients With Unresectable, or Oligo-Metastatic Cholangiocarcinoma Who Are Not Candidates for Curative Therapy (RAIDEN Trial)

This phase I trial tests the safety and side effects of yttrium-90 (Y90) radioembolization combined with immunotherapy drugs tremelimumab and durvalumab in tre…

Locally Advanced Intrahepatic CholangiocarcinomaOligometastatic Intrahepatic CholangiocarcinomaStage III Intrahepatic Cholangiocarcinoma AJCC v8+2 more

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositivePhiladelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive

~$150 – $3,000

Actual pay is set by the research site.

Phase 2

Ponatinib as Second Line Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib, Dasatinib or Nilotinib

This phase II trial studies how well ponatinib hydrochloride works as second line therapy in treating patients with chronic myeloid leukemia in chronic phase t…

M.D. Anderson Cancer CenterNCT01746836

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

A Phase 1/1b Study of IAM1363 in Participants With Advanced Cancers Harboring HER2 Alterations

This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 i…

HER2 Mutation-Related TumorsHER2HER2-positive Breast Cancer+10 more

Iambic Therapeutics, IncNCT06253871

~$150 – $4,200

Actual pay is set by the research site.

Phase 2

Androgen Replacement to Improve Patient-Important Outcomes in Men With Opioid-Induced Hypogonadism

The aim of this trial is to evaluate whether testosterone replacement results in greater improvement in pain perception, pain tolerance, sexual function, fatig…

Opioid UsePainHypogonadism, Male

Brigham and Women's HospitalNCT04798469

~$75 – $2,000

Actual pay is set by the research site.

Comprehensive Care for AYA: Needs Assessment Survey

The goal of this observational study is to assess gaps in education about exercise, sexual health, fertility, survivorship, financial issues, interpersonal rel…

CancerYoung Adult CancerAdolescent Cancer

Wake Forest University Health SciencesNCT07196241

Actual pay is set by the research site.

Multiple Chronic ConditionsAdverse Event

Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions

This study aims to predict and minimize post-discharge adverse events (AEs) during care transitions through early identification and escalation of patient-repo…

Brigham and Women's HospitalNCT05282654

Actual pay is set by the research site.

Phase 2

Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

This is a Phase 2, randomized two-armed, multi-site study of 138 patients with metastatic castrate sensitive prostate adenocarcinoma. Patients will be randomiz…

Prostate Adenocarcinoma